Jeraygo (aprocitentan) approved in Europe as first and only ERA for the treatment of resistant hypertension – Idorsia Ltd
Idorsia Ltd announced that the European Commission (EC) has approved Jeraygo (aprocitentan) for the treatment of resistant hypertension in adult patients in combination with at least three antihypertensive… read more.